MIC Injection MIC injections enhance the bodys natural fat-burning processes by improving the breakdown and utilization of stored fat for energy
In research and in clinical practice, BPC-157 has shown potential to: - Accelerate healing in muscles, tendons, ligaments, and joints - Reduce inflammation & pain so recovery can start sooner - Support gut health by protecting the intestinal lining - Improve vascular function, which may aid sexual health - Boost resilience to future injury by supporting tissue repair pathways BPC-157 works by sending powerful repair signals to cells, promoting regeneration, new blood vessel growth, and reduced inflammatory damage
Thus, this peptide can increase and accelerate blood flow in the area of injuries, which is normally very slow, it is very efficient in enhancing healing processes
503A pharmacy source matters: The before and after results we see at our clinic come from pharmaceutical-grade 503A compounded BPC-157
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
The headline results, as released in the Eli Lilly investor communication and aligned with the study design paper by Giblin and colleagues published in Diabetes, Obesity and Metabolism in 2026, are unusually strong for a Phase 3 obesity trial: Retatrutide 12 mg: mean body-weight reduction of 28.7 percent, roughly 32.3 kg (about 71.2 lbs) from baseline
